Investigate the Effect of AZD1305 on Patients With Left Ventricular Dysfunction

• Status: Completed
• Trial end date: 2009-07-01
• Target enrollment: 0
• Participant gender: All

Summary

To explore if AZD1305 compromises left ventricular performance in patients with left ventricular dysfunction

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: AstraZeneca

Criteria

Inclusion Criteria:

• Male patients and postmenopausal women

• Mildly/moderately decreased heart function

• Regular heart rhythm

Exclusion Criteria:

• Potassium outside normal reference values

• Child bearing potential

• Severely decreased heart function